MarketInOut Stock Screener Log In | Sign Up
 

Natera Inc

NASDAQ • Healthcare • Diagnostics & Research • Quote as of 10/02/2026 09:38
Natera Inc stock price and volume chart

Company Profile

IndustryDiagnostics & Research
SectorHealthcare
ExchangeNASDAQ
Market Capitalization59,314 mln
Float140 mln
Earnings Date11/11/2026

Piotroski F-Score

5 / 9
Neutral

Beneish M-Score

0.29
Highly suspicious

1-Year Forecast

352.80
Limited downside

Relative Strength

92 / 100
Top performer

Debt / Equity

0.13
Very low leverage

Pre-Tax Margin

-9%
Marginally loss-making

Business Description

Founded in 2003 and based in Austin, Texas, Natera develops and sells genetic testing services for use across oncology, women's health, and organ transplant care. Its tests help detect cancer recurrence, screen for hereditary conditions, support prenatal care, and monitor kidney and transplant health. The company works with hospitals, physician practices, research labs, and pharmaceutical companies, and also offers cloud-based software that allows partner labs to distribute its testing under license.

Key Fundamentals

EPS-1.36
ROE-12.32
RPS19.32
ROIC-23.18
ROA-8.55
Interest Cover-29.04
EBITDA, mln-183
EV / EBITDA-252
EV / EBIT-186
Revenue, mln2,707
EV / Revenue17.06

Quote Details

Last 412.68
Change 4.21 (1.03%)
Open 409.40
Volume 65,238
Turnover 26,922,418
Average Volume 1,484,935

Financial Ratios

Pre-Tax Profit Margin-9
Leverage Ratio1.46
Current Ratio3.00
Price / Book25.72
Price / Tangible Book35.50
Price / Cash Flow259
Price / Free Cash Flow882
Debt / Equity0.13
Price / Sales16.90

Financial Strength

Altman Z-Score33.42
Piotroski F-Score 5 / 9
Beneish M-Score0.29
1-Year Target Price352.80
Short Ratio4.12
Short % of Float3.43

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 0.03% 61 / 100   
1 Month 26.91% 95 / 100   
2 Months 57.57% 96 / 100   
6 Months 98.42% 96 / 100   
1 Year 155% 97 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Contact Us